(Press-News.org) If you are one of the millions of Americans with high blood pressure, more help is on the way. That's because a new research study published in the October 2010 print issue of The FASEB Journal (http://www.fasebj.org) shows that a protein, called P450, metabolizes arachidonic acid in our blood vessel walls to create a tiny molecule with a big name—epoxyeicosatrienoic acid (EET)—which in mice, turns off genes responsible for vascular inflammation and ultimately relaxes blood vessels to lower blood pressure. This protein and genes are also present in humans.
"We hope these results will help advance the development of new blood pressure lowering agents that increase EETs," said Craig R. Lee, M.D., from the National Institutes of Health's National Institute of Environmental Health Sciences in Research Triangle Park, N.C. "In particular, we hope that targeted-use of these new therapies in individuals with a poorly functioning P450-EET system will ultimately prove to be an effective treatment for patients with high blood pressure."
Lee and colleagues discovered this new protein using genetically modified mice with human P450 present in the cells lining the blood vessels, and using normal mice as a control group. The scientists found that the P450 caused the mice to produce EETs, which in turn caused the relaxation of blood vessels and lower blood pressure. When the mice were exposed to substances that increased blood pressure, the P450 mice had lower blood pressure and less damage to the kidneys than the normal mice. These results show that the P450-EET pathway is a target for the development of new blood pressure medications, and these findings may influence drug development for other diseases, such as coronary artery disease, stroke, and cancer.
"Whether you're a Type A personality, overweight and out of shape, or genetically wired to have high blood pressure, this research offers real hope," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal "Having discovered a pivotal role for the P450-EET system, scientists can now develop a new class of drugs not only for lowering blood pressure, but also for preventing strokes and heart attacks."
###
Receive monthly highlights from The FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal (http://www.fasebj.org) is published by the Federation of the American Societies for Experimental Biology (FASEB). The journal has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century and is the most cited biology journal worldwide according to the Institute for Scientific Information.
FASEB comprises 23 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve—through their research—the health, well-being and productivity of all people. FASEB's mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Details: Craig R. Lee, John D. Imig, Matthew L. Edin, Julie Foley, Laura M. DeGraff, J. Alyce Bradbury, Joan P. Graves, Fred B. Lih, James Clark, Page Myers, A. Ligon Perrow, Adrienne N. Lepp, M. Alison Kannon, Oline K. Ronnekleiv, Nabil J. Alkayed, John R. Falck, Kenneth B. Tomer, and Darryl C. Zeldin. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. FASEB J. 2010 24: 3770-3781. DOI: 10.1096/fj.10-160119 ; http://www.fasebj.org/cgi/content/abstract/24/10/3770
Scientists discover a new way our bodies control blood pressure: the P450-EET system
New research in the FASEB Journal suggests that increasing the level of the P450 protein causes the creation of molecules called EETs, which lower blood pressure
2010-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Scientists define molecular on-off switches for cancer and autoimmunity
2010-10-01
A new report published in the October 2010 print issue of The FASEB Journal (http://www.fasebj.org) offers a ray of hope in the search for new cancer drugs. By examining the seemingly conflicting roles of how oncogenes and tumor suppressor genes handle cellular stress, scientists from the Institute for Advanced Studies in New Jersey argue that each of these opposing systems could be potent drug targets in the effort to stop cancer. In addition, their hypothesis provides new insights into what contributes to immunological disorders such as chronic inflammation and autoimmune ...
Scientists reveal important clues to how bacteria and viruses are identified as enemies
2010-10-01
A new research report in the October 2010 print issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) sheds important light on how our immune systems detect invading organisms to be destroyed and removed from our bodies. The information from this research should ultimately help lead to the development of new drugs and treatments that allow health care providers to prevent runaway immune reactions that can have devastating consequences for people.
"Our study helps us to understand exactly how the immune system is activated when it comes across infection ...
Statement: Study finds genital herpes vaccine ineffective in women
2010-10-01
An experimental vaccine intended to prevent genital herpes disease in women, although generally safe and well-tolerated, proved ineffective when tested in the recently concluded clinical study known as the Herpevac Trial for Women.
The Phase 3 trial, sponsored by GlaxoSmithKline (GSK) Biologicals, based in Belgium, with support from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, began in 2002. A total of 8,323 women aged 18-30 years participated in the trial at 50 sites in the United States and Canada. At ...
Age 50 as mammography screening threshold proven unfounded
2010-10-01
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent. The results of this largest study ever conducted on women in this age group confirm that the use of the age of 50 as a threshold for breast cancer screening is scientifically unfounded. Women should begin getting annual mammograms at age 40.
"This study, which looked at the performance of screening mammography as it is actually used, rather than ...
Why do some dialysis centers have higher survival rates?
2010-10-01
Characteristics such as patient engagement, physician communication, and staff coordination may help to explain why some dialysis centers achieve higher patient survival rates than others, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
"The purpose of this study was simple: to figure out what top-performing dialysis units might be doing differently from bottom-performing units, and to translate those findings into a blueprint for action," comments Brennan M.R. Spiegel, MD, MSHS (VA Greater Los ...
Epigenomics discovery yields new information about fat cells
2010-10-01
BOSTON –By creating a "map" of histone modifications in fat cells, investigators have discovered two new factors that regulate fat formation, a key step on the road to better understanding obesity, diabetes and other metabolic disorders. Led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and the Broad Institute, the study appears in the October 1 issue of the journal Cell.
"These findings help to demonstrate the power of epigenomic mapping when it comes to gleaning key insights into fat cell formation," explains senior author Evan Rosen, MD, PhD, an ...
Poor kidney function linked to future heart and brain problems
2010-10-01
People with impaired kidney function are at a higher risk of future stroke than people with normal kidney function, concludes a study published on bmj.com today.
A second study, also published today, finds that even the earliest stages of chronic kidney disease are linked to a higher risk of coronary heart disease.
This study suggests that considering signs of early kidney disease, in addition to routinely measured risk factors such as blood pressure and blood cholesterol, modestly improves the identification of people at high risk of cardiovascular disease. It provides ...
New strategy could reduce twin rate after IVF
2010-10-01
A strategy to encourage single embryo transfer after in vitro fertilisation (IVF) could be an important tool to prevent multiple pregnancies and their associated complications, finds a study published on bmj.com today.
Deciding how many embryos should be transferred after IVF is a complex problem. The transfer of only one embryo will prevent a multiple pregnancy and the risk of complications for mother and baby, but could require more cycles to achieve pregnancy.
Although professionals and policy makers have launched initiatives to encourage the use of single embryo ...
Drugs for low libido raise concerns over industry 'construction' of new diseases
2010-10-01
Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ.
Researching his new book 'Sex, Lies and Pharmaceuticals' Ray Moynihan, journalist and lecturer at the University of Newcastle in Australia, discovered that drug industry employees have worked with paid key opinion leaders to help develop the disease entity; they have run surveys to portray it as widespread; and they helped design diagnostic tools ...
Should athletes undergo mandatory ECG screening?
2010-10-01
Should athletes have to undergo mandatory electrocardiographic screening (also known as ECG or heart trace) before competing? Doctors debate the issue in this week's BMJ.
Antonio Pelliccia and Domenico Corrado argue that screening athletes for "silent" heart problems would save lives. They say the best evidence of the efficacy of ECG screening on mortality in athletes comes from Italy, the only country where it is required by law, and where a mass screening programme has been in place for almost 30 years.
The incidence of sudden deaths before and after implementation ...
LAST 30 PRESS RELEASES:
Greasing the wheels of the energy transition to address climate change and fossil fuels phase out
Researchers discover accelerated reaction between Criegee intermediates and water via roaming mechanism
Physical and psychological symptoms of ketamine abuse revealed in research
Global virus network issues urgent call to action to mitigate the rising threat of H5N1 avian influenza
Noto quake 3D model adds dimension to understand earthquake dynamics
Chip-shop fish among key seabed engineers
Genetic-based tool improves pancreatic cancer treatment decisions
Long-term survival rates of some Acute Myeloid Leukaemia patients could double with sensitive bone marrow test
Billion-year-old impact in Scotland sparks questions about life on land
High blood sugar in adolescence tripled the risk of premature heart damage affecting females worse than males
A neuro-quantum leap in finding optimal solutions
Brain decoder controls spinal cord stimulation
UCLA receives $25 million from Shirley and Walter Wang to establish new integrative digestive health center
Sexual trauma during military service linked to higher risk of suicide and overdose death later in life
New non-invasive brain stimulation technique shows significant reduction in depression, anxiety and PTSD symptoms
Toward defining problematic media usage patterns in adolescents
New insight into how the brain switches gears could help Parkinson’s patients
Dopamine signals when a fear can be forgotten
Anatomy of a “zombie” volcano: investigating the cause of unrest inside Uturuncu
Some dogs, cats bred to evolve same ‘smushed’ faces
Sexism undermines teams by disrupting emotional synchrony’s role in performance
‘Extremely rare event’: bone analysis suggests ancient echidnas lived in water
Flood risk increasing in Pacific Northwest
First synthetic ‘mini prion’ shows how protein misfolding multiplies
BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation
A new method identifies rancid hazelnuts without removing them from the bag
How math helps to protect crops from invasive disease
Study using simulations highlights power of pooled data in environmental health research
Flower strips could save apple farmers pest control costs
Rats are more motivated to help their friends
[Press-News.org] Scientists discover a new way our bodies control blood pressure: the P450-EET systemNew research in the FASEB Journal suggests that increasing the level of the P450 protein causes the creation of molecules called EETs, which lower blood pressure